A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Smoking is a leading cause of preventable death, causing about 5 million premature deaths worldwide each year. Evidence for genetic influence on smoking behaviour and nicotine dependence (ND) has prompted a search for susceptibility genes. Furthermore, assessing the impact of sequence variants on smoking-related diseases is important to public health. Smoking is the major risk factor for lung cancer (LC) and is one of the main risk factors for peripheral arterial disease (PAD). Here we identify a common variant in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with an effect on smoking quantity, ND and the risk of two smoking-related diseases in populations of European descent. The variant has an effect on the number of cigarettes smoked per day in our sample of smokers. The same variant was associated with ND in a previous genome-wide association study that used low-quantity smokers as controls, and with a similar approach we observe a highly significant association with ND. A comparison of cases of LC and PAD with population controls each showed that the variant confers risk of LC and PAD. The findings provide a case study of a gene-environment interaction, highlighting the role of nicotine addiction in the pathology of other serious diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These biobank efforts, pioneered in studies such as the Framingham Cohort70 and the efforts of DeCODE in Iceland71,72, now encompass a growing inventory of national cohorts in North America, Europe, Asia and beyond73–76.”
From A brief history of human disease genetics (2020) · cites this paper as [72]
In the citing paper
“This association has been replicated either directly or using highly correlated SNPs by several groups (92–97).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“The replicated nicotine dependence loci tagged by rs16969968 (96,100–102) and rs578776 (101,103) have also been reported to influence lung cancer risk in several genome-wide association studies.”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“This second association with nicotine dependence has been replicated in additional studies using the same SNP or a highly correlated SNP (92,95,96,98).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
In the citing paper
“some indicate that the association could be explained through an indirect effect on risk for smoking (96)”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [96]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Recommended standards for reports dealing with lower extremity ischemia: Revised version
Rutherford, R. B., Baker, J. D., Ernst, C., Johnston, K. W., Porter, J. M., Ahn, S., & Jones, D. N. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70045-4 · Cited by 3,562
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Self-citationGenotype-environment interaction and correlation in the analysis of human behavior.
Plomin, R., DeFries, J. C., & Loehlin, J. C. (1977) · Psychological Bulletin · doi:10.1037/0033-2909.84.2.309 · Cited by 1,685
Dormandy, J., & Rutherford, R. B. (2000) · PubMed · Cited by 1,635
Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Cited by
Items 401–500 of 1,002
Nicotine Reduction: Strategic Research Plan
Hatsukami, D. K., Benowitz, N. L., Donny, E. C., Henningfield, J. E., & Zeller, M. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts214 · Cited by 61
“Understanding the neurobiology of nicotine addiction has advanced significantly (D’Souza & Markou, 2011; Gotti, Zoli, & Clementi, 2006; Kuryatov, Berrettini, & Lindstrom, 2011; Saccone et al., 2009; Thorgeirsson et al., 2008; Tuesta, Fowler, & Kenny, 2011).”
Self-regulation and control in personality functioning
Carver, C. S., & Scheier, M. F. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596544.027 · Cited by 62
Novel perspectives in cancer therapy: Targeting ion channels
Arcangeli, A., & Becchetti, A. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.06.002 · Cited by 62
Chen, G., Xu, Y., Xu, H., Li, M. D., Zhu, J., & Lou, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016981 · Cited by 62
“We employed a balanced experimental design with three moderate sample sizes (500, 1000, and 2000) and two large samples (4000 and 10,000) because large samples have been more prevalent in many recent reports [47,48,49].”
Method‘Smoking Genes’: A Genetic Association Study
Verde, Z., Santiago, C., González-Moro, J. M. R., Ramos, P. D. L., Martín, S. L., Bandrés, F., Lucía, A., & Gómez‐Gallego, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026668 · Cited by 61
Pharmacogenetics of Nicotine Addiction: Role of Dopamine
Herman, A. I., DeVito, E. E., Jensen, K. P., & Sofuoglu, M. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.246 · Cited by 68
Genetics of COPD and Emphysema
Wan, E. S., & Silverman, E. K. (2009) · CHEST Journal · doi:10.1378/chest.09-0555 · Cited by 64
Kaur-Knudsen, D., Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.9870 · Cited by 58
Broms, U., Wedenoja, J., Largeau, M. R., Korhonen, T., Pitkäniemi, J., Keskitalo-Vuokko, K., Häppölä, A., Heikkilä, K. H., Heikkilä, K., Ripatti, S., et al. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr283 · Cited by 60
“Larger samples may be needed to detect significant association with CPD, as shown by a study of over 13,000 Icelandic smokers (Thorgeirsson et al., 2008) in which variation in Locus 1 (rs1051730) accounted for only about 1% of the variance in CPD, the average effect per allele being about 1 CPD (Thorgeirsson et al.”
BackgroundMethodResultInfluentialA gene-based risk score for lung cancer susceptibility in smokers and ex-smokers
Young, R. P., Hopkins, R. J., Hay, B. A., Epton, M., Mills, G., Black, P., Gardner, H. D., Sullivan, R., & Gamble, G. D. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.077107 · Cited by 63
Uhl, G. R., Drgon, T., Johnson, C., Ramoni, M. F., Behm, F. M., & Rose, J. E. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00052 · Cited by 62
Nicotinic acetylcholine receptors: upregulation, age‐related effects and associations with drug use
Melroy‐Greif, W. E., Stitzel, J. A., & Ehringer, M. A. (2016) · Genes, Brain and Behavior · doi:10.1111/gbb.12251 · Cited by 55
“…al. 2012; Chen et al. 2009; Erlich et al. 2010; Haller et al. 2012; Maes et al. 2011; Saccone et al. 2009a,b; Sherva et al. 2010; Spitz et al. 2008; Thorgeirsson et al. 2008; Weiss et al. 2008; Wessel et al. 2010), but more recently the genes for other nAChR subunits have been associated with…”
BackgroundYoon, D., Kim, Y.-J., Cui, W.-Y., Van der Vaart, A., Cho, Y. S., Lee, J.-Y., Ma, J. Z., Payne, T. J., Li, M. D., & Park, T. (2012) · Human Genetics · doi:10.1007/s00439-011-1102-x · Cited by 57
Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models
Brunzell, D. H., Stafford, A. M., & Dixon, C. I. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0042-2 · Cited by 64
Integrin signaling and lung cancer
Caccavari, F., Valdembri, D., Sandri, C., Bussolino, F., & Serini, G. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.1.10976 · Cited by 65
“Recently, genome wide association studies identified an association between single nucleotide polymorphism in nicotinic acetylcholine receptor subunit genes and susceptibility to lung cancer.(23,24) Of note, the main tobacco alkaloid nicotine stimulates lung cancer cell growth by inducing FN synthesis.”
BackgroundYoung, R. P., & Whittington, C. F. (2010) · The Application of Clinical Genetics · doi:10.2147/tacg.s15758 · Cited by 66
“Lung cancer GWA studies have successfully identified several novel susceptibility loci, 11–13 but these studies may have severely underestimated the contribution of COPD and its underlying genetic determinants of lung cancer (“ COPD-related” genes, Figure 1).”
InfluentialMeta-Analysis of 15 Genome-Wide Linkage Scans of Smoking Behavior
Han, S., Gelernter, J., Luo, X., & Yang, B.-Z. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.028 · Cited by 58
Interpreting Behavior Genetic Models: Seven Developmental Processes to Understand
Briley, D. A., Livengood, J., Derringer, J. L., Tucker–Drob, E. M., Fraley, R. C., & Roberts, B. W. (2018) · Behavior Genetics · doi:10.1007/s10519-018-9939-6 · Cited by 65
Nicotine-Modulated Subunit Stoichiometry Affects Stability and Trafficking of 3 4 Nicotinic Receptor
Mazzo, F., Pistillo, F., Grazioso, G., Clementi, F., Borgese, N., Gotti, C., & Colombo, S. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2393-13.2013 · Cited by 62
The nicotinic cholinergic system function in the human brain
Nees, F. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.021 · Cited by 66
Role of c-Met in Cancer: Emphasis on Lung Cancer
Salgia, R. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.02.008 · Cited by 57
Inherited lung cancer: a review
de Alencar, V. T. L., Formiga, M. N., & de Lima, V. C. C. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1008 · Cited by 74
Genome Wide Association for Addiction: Replicated Results and Comparisons of Two Analytic Approaches
Drgon, T., Zhang, P.-W., Johnson, C., Walther, D. M., Hess, J., Nino, M., & Uhl, G. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008832 · Cited by 60
“Contributions of nicotinic receptor gene variants to individual differences in smoking quantity [6–10] and acetaldehyde dehydrogenase/alcohol dehydrogenase variants to risk for alcohol dependence in Asians may provide larger effects of variants at single loci [11,12].”
Nicotine Enhances Excitability of Medial Habenular Neurons via Facilitation of Neurokinin Signaling
Dao, D. Q., Perez, E. E., Teng, Y., Dani, J. A., & De Biasi, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2736-13.2014 · Cited by 56
“Genetic variants in the CHRNA5/ CHRNA3/CHRNB4 gene cluster, which encodes the 5, 3, and 4 nAChR subunits (Duga et al., 2001), were found in genomic studies to influence various aspects of nicotine addiction (Saccone et al., 2007; Bierut et al., 2008; Thorgeirsson et al., 2008).”
BackgroundMethodInfluentialNeurophysiology of Nicotine Addiction
Dani, J. A., Jenson, D., Broussard, J. I., & Biasi, M. D. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-001 · Cited by 59
“It is intriguing and likely not a coincidence that a single nucleotide polymorphism (SNP) within the α5 gene (CHRNA5) reduces α5-nAChR function and correlates with greater nicotine dependence risk, heavier smoking, and increased pleasurable sensation from cigarettes [108-111].”
BackgroundHoft, N. R., Corley, R. P., McQueen, M. B., Huizinga, D. H., Menard, S., & Ehringer, M. A. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00495.x · Cited by 58
“…(Amos et al. 2008; Berrettini et al. 2008; Bierut et al. 2007; Ehringer et al. 2007; Hung et al. 2008; Saccone et al. 2007; Schlaepfer et al. 2008a; Thorgeirsson et al. 2008; Zeiger et al. 2008) and they have been associated with alcohol dependence in the COGA (Collaborative Studies on the…”
BackgroundShi, J., Chatterjee, N., Rotunno, M., Wang, Y., Pesatori, A. C., Consonni, D., Li, P., Wheeler, W., Broderick, P., Henrion, M., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0246 · Cited by 64
Validity of Recall of Tobacco Use in Two Prospective Cohorts
Brigham, J., Lessov-Schlaggar, C. N., Javitz, H. S., Krasnow, R. E., Tildesley, E., Andrews, J., Hops, H., Cornelius, M. D., Day, N. L., McElroy, M., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq179 · Cited by 55
Twins and the mystery of missing heritability: the contribution of gene–environment interactions
Kaprio, J. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02587.x · Cited by 54
Pharmacogenetics of Nicotine and Associated Smoking Behaviors
Tanner, J., Chenoweth, M. J., & Tyndale, R. F. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_3 · Cited by 68
Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases
Ziółkowska‐Suchanek, I., Mosor, M., Gabryel, P., Grabicki, M., Żurawek, M., Fichna, M., Strauss, E., Batura‐Gabryel, H., Dyszkiewicz, W., & Nowak, J. (2015) · Scientific Reports · doi:10.1038/srep13502 · Cited by 60
Bae, E. Y., Lee, S. Y., Kang, B. K., Lee, E. J., Choi, Y. Y., Kang, H., Choi, J. E., Jeon, H.-S., Lee, W. K., KAM, S., et al. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02165.x · Cited by 55
Common and specific liability to addiction: Approaches to association studies of opioid addiction
Nielsen, D. A., & Kreek, M. J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.03.026 · Cited by 59
“A series of studies of nicotine dependence including a large-scale GWAS of lung cancer (Thorgeirsson et al., 2008) implicated variants in the alpha 5-alpha 3-beta 4 nicotinic cholinergic receptor gene cluster (for review see (Bierut, 2010)).”
BackgroundEtiology of lung cancer: Evidence from epidemiologic studies
Zou, K., Sun, P., Huang, H., Zhuo, H., Qie, R., Xie, Y., Luo, J., Li, N., Li, J., He, J., et al. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.09.004 · Cited by 77
Breitling, L., Dahmen, N., Mittelstrass, K., Rujescu, D., Gallinat, J., Fehr, C., Giegling, I., Lamina, C., Illig, T., Müller, H., et al. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.6 · Cited by 57
LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer
Wb, L., JIANG, X. H., Han, F., Yh, L., Hq, C., Liu, Y., Cao, J., & Jy, L. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.366 · Cited by 58
Crucial role of nicotinic α5 subunit variants for Ca2+fluxes in ventral midbrain neurons
Sciaccaluga, M., Moriconi, C., Martinello, K., Catalano, M., Bermúdez, I., Stitzel, J. A., Maskos, U., & Fucile, S. (2015) · The FASEB Journal · doi:10.1096/fj.14-268102 · Cited by 57
“Recently, the a5 subunit containing the nonsynonymous variant rs16969968, a single nucleotide polymorphism in which the aspartic acid residue at position 398 is replaced with an asparagine (a5DN), has been associated with increased use of tobacco (9, 10) and with a higher incidence of lung cancer (11, 12).”
BackgroundEnvironmental Confounding in Gene-Environment Interaction Studies
VanderWeele, T. J., Ko, Y.-A., & Mukherjee, B. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws439 · Cited by 59
Dubey, S., & Powell, C. A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0289up · Cited by 65
Brothers, J. F., Hijazi, K., Mascaux, C., El‐Zein, R. A., Spitz, M. R., & Spira, A. E. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-168 · Cited by 57
“Several regions in the genome associated with lung cancer and/or COPD have been identified, including chromosome 1q21, 4q22, 4q24, 4q31, 5p15, 5q32, 6p21, 6q24, 15q25 and19q13 [9,10,41-49].”
BackgroundGenome-Wide Association Studies for Atherosclerotic Vascular Disease and Its Risk Factors
Ding, K., & Kullo, I. J. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.816751 · Cited by 57
Ocak, S., Sos, M. L., Thomas, R. K., & Massion, P. P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00042409 · Cited by 57
Vansteelandt, S., Goetgeluk, S., Lutz, S., Waldman, I., Lyon, H., Schadt, E. E., Weiss, S. T., & Lange, C. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20393 · Cited by 51
Zhong, X., Drgonová, J., Li, C., & Uhl, G. R. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12776 · Cited by 59
Qin, J., Zhang, H., Li, P., Albanes, D., & Yu, K. J. (2014) · Biometrika · doi:10.1093/biomet/asu048 · Cited by 66
REVIEW: Cognitive effects of nicotine: genetic moderators
Herman, A. I., & Sofuoglu, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00213.x · Cited by 49
“…that several polymorphisms in genes that encode nAChR subunits (CHRNA2–CHRNA10 and CHRNB2–CHRNB4) relate to FTND score, smoking quantity, subjective response as well as other smokingrelated behaviors (Hutchison et al. 2007; Saccone et al. 2007; Portugal & Gould 2008; Thorgeirsson et al. 2008).”
BackgroundBessa, C., Maciel, P., & Rodrigues, A. J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8434-6 · Cited by 57
“CHRNA3 Nicotinic acetylcholine receptors (nAChR) acr-2 mutants present spontaneous muscle convulsions due to cholinergic excitation and decreased GABAergic inhibition [145] Associated with lung cancer [279].”
BackgroundIntra-Person Variation of Urinary Biomarkers of Oxidative Stress and Inflammation
Wu, X., Cai, H., Xiang, Y., Cai, Q., Yang, G., Liu, D., Sanchez, S. C., Zheng, W., Milne, G. L., & Shu, X. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0046 · Cited by 54
Explanatory pluralism in the medical sciences: Theory and practice
VREESE, L. D., Weber, E., & BOUWEL, J. V. (2010) · Metamedicine · doi:10.1007/s11017-010-9156-7 · Cited by 64
“In 2008, three research teams reported the identification of specific gene variants that would make some smokers more susceptible to lung cancer than others [3] [4] [5] [6].”
BackgroundGuo, W., & Lin, S. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20382 · Cited by 51
“…genome association studies have indeed surged recently in popularity as technological advances have made large-scale genotyping more feasible and as new exciting results offer tremendous hope and optimism [Chanock and Hunter, 2008; Hung et al., 2008; Thorgeirsson et al., 2008; Amos, et al., 2008].”
BackgroundPersonality in cross-cultural perspective
Dragūns, J. G. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596544.035 · Cited by 53
Shi, C., de Wit, S., Učambarlić, E., Markousis‐Mavrogenis, G., Screever, E. M., Meijers, W. C., de Boer, R. A., & Aboumsallem, J. P. (2023) · Cancers · doi:10.3390/cancers15030729 · Cited by 55
Yin, J., Huang, Q., Zhao, Y.-C., Zhou, H.-H., & Liu, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038150 · Cited by 53
“On the other hand, GWAS have been successfully used in disease susceptibility and pharmacogenetic research [47–50].”
Current Status on Biochemistry and Molecular Biology of Microbial Degradation of Nicotine
Gurusamy, R., & Natarajan, S. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/125385 · Cited by 55
“Nicotine is a hazardous compound that causes tobacco related lung cancer and peripheral arterial disease [10].”
BackgroundGenome-wide association studies of late-onset cardiovascular disease
Smith, J. G., & Newton‐Cheh, C. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.004 · Cited by 56
“Furthermore, there is evidence that a missense variant in the nicotinic acetylcholine receptor gene cluster is associated with both nicotine dependence and lower limb ischemia, potentially corroborating the wellestablished role for smoking in this disease as for other atherosclerotic disease manifestations [43].”
Kazma, R., Babron, M., Gaborieau, V., Génin, E., Brennan, P., Hung, R. J., McLaughlin, J. R., Krokan, H. E., Elvestad, M. B., Skorpen, F., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs116 · Cited by 53
Vincamine, a safe natural alkaloid, represents a novel anticancer agent
Al-Rashed, S. A., Baker, A., Ahmad, S. S., Syed, A., Bahkali, A. H., Elgorban, A. M., & Khan, M. S. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104626 · Cited by 53
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
Ritsner, M. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9464-4 · Cited by 55
“Thus, it is vital that the study samples are described in a manner that permits study replication, as failure to do so is associated with an inappropriate elevation of effect sizes.(10) Unfortunately this is not always done and has limited”
BackgroundNicotinic acetylcholine receptor signaling in atherogenesis
Santanam, N., Thornhill, B. A., Lau, J. K., Crabtree, C. M., Cook, C. R., Brown, K. C., & Dasgupta, P. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.041 · Cited by 54
“Most interestingly, amongst the genes in this region are a3-nAChR, a5nAChR and b4-nAChR, which play a vital role in nicotine addiction [35].”
BackgroundGenetic Influences on Peripheral Arterial Disease in a Twin Population
Wahlgren, C. M., & Magnusson, P. K. E. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.210385 · Cited by 51
Genome-Wide Gene-by-Smoking Interaction Study of Chronic Obstructive Pulmonary Disease
Kim, W., Prokopenko, D., Sakornsakolpat, P., Hobbs, B. D., Lutz, S. M., Hokanson, J. E., Wain, L. V., Melbourne, C., Shrine, N. R. G., Tobin, M. D., et al. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa227 · Cited by 52
Dopamine Genes and Nicotine Dependence in Treatment-Seeking and Community Smokers
Bergen, A. W., Conti, D. V., Berg, D. V. D., Lee, W., Liu, J., Li, D., Guo, N., Mi, H., Thomas, P. D., Lessov‐Schlaggar, C. N., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.52 · Cited by 52
“…smoking (≥ 25 cigarettes per day (CPD) versus 5 CPD) in population based and clinical based samples originally recruited for other genetic studies (Berrettini et al., 2008), and with cigarettes smoked per day in smokers originally recruited for other genetic studies (Thorgeirsson et al., 2008).”
BackgroundInfluentialLung Cancer in Never Smokers: A Call to Action
Rudin, C. M., Ávila-Tang, É., & Samet, J. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0373 · Cited by 58
Ruyck, K. D., Nackaerts, K., Beels, L., Werbrouck, J., Volder, A. D., Meysman, M., Salhi, B., van Meerbeeck, J. P., & Thierens, H. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.75 · Cited by 53
Uhl, G. R., Drgon, T., Johnson, C., Walther, D. M., David, S. P., Aveyard, P. N., Murphy, M. F., Johnstone, E. C., & Munafo, M. R. (2010) · Pharmacogenomics · doi:10.2217/pgs.09.156 · Cited by 52
Krais, A. M., Hautefeuille, A. H., Cros, M., Krutovskikh, V. A., Tournier, J., Birembaut, P. L., Thepot, A., Paliwal, A., Herceg, Z., Boffetta, P., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr090 · Cited by 57
Çolak, Y., Afzal, S., Lange, P., & Nordestgaard, B. G. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty077 · Cited by 51
The habenular G-protein–coupled receptor 151 regulates synaptic plasticity and nicotine intake
Antolin-Fontes, B., Li, K., Ables, J. L., Riad, M. H., Görlich, A., Williams, M., Wang, C., Lipford, S. M., Dao, M., Liu, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916132117 · Cited by 44
“Little was known about the MHb in regulating the motivational properties of nicotine until human genetics studies established a strong association between genetic variants in the CHRNB4–A3–A5 gene cluster and smoking dependence (16), indicating that these nAChR subtypes are critical for acquisition of nicotine depende…”
BackgroundCancer Risk Assessment Using Genetic Panel Testing: Considerations for Clinical Application
Hiraki, S. C., Rinella, E. S., Schnabel, F. R., Oratz, R., & Ostrer, H. (2014) · Journal of Genetic Counseling · doi:10.1007/s10897-014-9695-6 · Cited by 50
El‐Zein, R. A., Young, R. P., Hopkins, R. J., & Etzel, C. J. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0042 · Cited by 52
Inhibition of Nonneuronal α7-Nicotinic Receptor for Lung Cancer Treatment
Paleari, L., Negri, E., Catassi, A., Cilli, M., Servent, D., D’Angelillo, R. M., Cesario, A., Russo, P., & Fini, M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-908oc · Cited by 52
“Whereas Hung and colleagues (9) and Amos and colleagues (10) found that variants significantly increased the risk of primary lung cancer, but are independent smoking risk factors, Thorgeirsson and colleagues (11) strongly associated the variant Rs1051730 with lung cancer risk and smoking behavior.”
RetractedKim, W. J., Wood, A. M., Barker, A. F., Brantly, M., Campbell, E. J., Eden, E., McElvaney, N. G., Rennard, S. I., Sandhaus, R. A., Stocks, J. M., et al. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-16 · Cited by 51
“Three recent GWA studies showed that SNPs in a region of chromosome 15q25 were significantly associated with lung cancer; several nicotinic acetylcholine receptor genes, including CHRNA3 and LOC123688, are located in this region [12-14].”
The evolving discipline of molecular epidemiology of cancer
Spitz, M. R., & Bondy, M. L. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp246 · Cited by 51
Zhu, A. Z. X., Zhou, Q., Cox, L. S., David, S. P., Ahluwalia, J. S., Benowitz, N. L., & Tyndale, R. F. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.88 · Cited by 52
“CHRNA5-A3-B4 and smoking abstinence In Caucasians, a number of studies have examined the association between CHRNA5-A3-B4 gene variants and clinical trial outcomes for quitting smoking.”
BackgroundInfluentialDrgon, T., Johnson, C., Walther, D. M., Albino, A. P., Rose, J. E., & Uhl, G. R. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00040 · Cited by 49
Chronic Obstructive Pulmonary Disease Genetics: A Review of the Past and a Look Into the Future
Hardin, M. E., & Silverman, E. K. (2014) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.1.1.2014.0120 · Cited by 58
Liu, C., Cui, H., Gu, D., Zhang, M., Fang, Y., Chen, S., Tang, M., Zhang, B., & Chen, H. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.08.026 · Cited by 52
Etter, J., Hoda, J., Perroud, N. A., Munafo, M. R., Burési, C., Duret, C., Neidhart, E., Malafosse, A., & Bertrand, D. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.05.010 · Cited by 48
“…& van der Kooy, 2004; Li et al., 2005; Lou et al., 2006; Lueders et al., 2002; Saccone et al., 2007; Silverman et al., 2000; Spitz, Amos, Dong, Lin, & Wu, 2008; Sullivan et al., 2004; Thorgeirsson et al., 2008; Voineskos et al., 2007; Weiss +41 22 379 59 12. ter). ll rights reserved. et al., 2008).”
Kullo, I. J., Shameer, K., Jouni, H., Lesnick, T. G., Pathak, J., Chute, C. G., & de Andrade, M. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00166 · Cited by 48
Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy
de Alencar, V. T. L., Figueiredo, A. B., Corassa, M. P., Gollob, K. J., & de Lima, V. C. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.984349 · Cited by 52
Genetic differences between smokers and never-smokers with lung cancer
Kuśnierczyk, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1063716 · Cited by 56
Mroziewicz, M., & Tyndale, R. F. (2010) · PubMed Central · Cited by 67
Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers.
Sakoda, L. C., Loomis, M. M., Doherty, J. A., Julianto, L., Barnett, M. J., Neuhouser, M. L., Thornquist, M. D., Weiss, N. S., Goodman, G. E., & Chen, C. (2012) · PubMed Central · Cited by 54
A cis-Phase Interaction Study of Genetic Variants Within the MAOA Gene in Major Depressive Disorder
Zhang, J., Chen, Y., Zhang, K., Yang, H., Sun, Y., Fang, Y., Shen, Y., & Xu, Q. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.004 · Cited by 55
Tang, H., Wei, P., Duell, E. J., Risch, H. A., Olson, S. H., Bueno-de-Mesquita, H. B., Gallinger, S., Holly, E. A., Petersen, G. M., Bracci, P. M., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu010 · Cited by 47
“lung cancer and COPD [7,8], we also examined nicotine dependence related gene ontology (GO) pathways in the current study.”
BackgroundGenetics and Genomics of Chronic Obstructive Pulmonary Disease
Silverman, E. K., Spira, A. E., & Paré, P. D. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200904-021ds · Cited by 51
“Thorgeirsson (2008) ( 14 ) Nicotine addiction (cigarettes per day as a categorical variable) 15,771 subjects rs1051730 Combined P 5 6 3 10 220”
BackgroundSchaal, C. M., & Chellappan, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156451 · Cited by 50
“Polymorphisms in this region were found to correlate with nicotine dependence, number of cigarettes smoked per day, and increased risk for lung cancer development [29].”
BackgroundThe Role of Nicotine in Schizophrenia
Featherstone, R. E., & Siegel, S. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.07.002 · Cited by 53
A Novel Genetic Variant in Long Non-coding RNA Gene NEXN-AS1 is Associated with Risk of Lung Cancer
Yuan, H., Liu, H., Liu, Z., Owzar, K., Han, Y., Su, L., Wei, Y., Hung, R. J., McLaughlin, J. R., Brhane, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep34234 · Cited by 47
“1 that was also reported by multiple studies 5,10,21 .”
BackgroundYuan, J., Nelson, H. H., Butler, L. M., Carmella, S. G., Wang, R., Kuriger, J. K., Adams‐Haduch, J. M., Hecht, S. S., Gao, Y.-T., & Murphy, S. E. (2016) · International Journal of Cancer · doi:10.1002/ijc.29963 · Cited by 48
Rate of flow of aqueous humor determined from measurements of aqueous flare.
McLaren, J. W., Trocmé, S. D., Relf, S. J., & Brubaker, R. F. (1990) · PubMed · Cited by 54
Gabrielsen, M. E., Romundstad, P., Langhammer, A., Krokan, H. E., & Skorpen, F. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.26 · Cited by 46
Ślimak, M. A., Ables, J. L., Frahm, S., Antolin-Fontes, B., Santos-Torres, J., Moretti, M., Gotti, C., & Ibañez-Tallon, I. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00012 · Cited by 41
McKeigue, P., Campbell, H. J., Wild, S. H., Vitart, V., Hayward, C., Rudan, I., Wright, A. F., & Wilson, J. F. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp397 · Cited by 49
Landmarks in the History of Cancer Epidemiology
Greenwald, P., & Dunn, B. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0416 · Cited by 50
“In addition, a recent study of geneenvironment interactions identified polymorphisms in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with effects on smoking quantity, nicotine dependence, and the risk of lung cancer and peripheral artery disease in populations of European descent (98).”
BackgroundBiomarkers of Tobacco Smoke Exposure
Mattes, W. B., Yang, X., Orr, M. S., Richter, P., & Mendrick, D. L. (2014) · Advances in clinical chemistry · doi:10.1016/bs.acc.2014.09.001 · Cited by 52
Skaaby, T., Taylor, A. E., Jacobsen, R. K., Paternoster, L., Thuesen, B. H., Ahluwalia, T. S., Larsen, S. C., Zhou, A., Wong, A., Gabrielsen, M. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01977-w · Cited by 46
The Long-Term Consequences of Vietnam-Era Conscription and Genotype on Smoking Behavior and Health
Schmitz, L., & Conley, D. (2015) · Behavior Genetics · doi:10.1007/s10519-015-9739-1 · Cited by 53
“Genetically-at-risk smokers tend to not only smoke more, but may also experience increased toxin exposure at fixed quantities of smoking, and are at increased risk for heart disease and lung cancer (Le Marchand et al. 2008; Thorgeirsson et al. 2008; Spitz et al. 2008).”
BackgroundPolymorphic Variants of Cytochrome P450
Daly, A. K. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.03.001 · Cited by 65
Comparison of Pathway Analysis Approaches Using Lung Cancer GWAS Data Sets
Fehringer, G., Liu, G., Briollais, L., Brennan, P., Amos, C. I., Spitz, M. R., Bickeböller, H., Wichmann, H. ‐., Risch, A., & Hung, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031816 · Cited by 50
“The association of this pathway with risk is not unexpected as several SNPs at or near the CHRNA3-CHRNA5CHRNB4 gene cluster are associated with both lung cancer risk [1,2,5] and nicotine addiction [5,23,24].”
Background
Metadata
- Authors
- Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., Stacey, S. N., Bergthorsson, J. T., Thorlacius, S., Gudmundsson, J., Jonsson, T., Jakobsdottir, M., Saemundsdottir, J., Olafsdottir, O., Gudmundsson, L. J., Bjornsdottir, G., Kristjansson, K., Skuladottir, H., Isaksson, H. J., Gudbjartsson, T., Jones, G. T., Mueller, T., Gottsäter, A., Flex, A., Aben, K. K. H., de Vegt, F., Mulders, P. F. A., Isla, D., Vidal, M. J., Asin, L., Saez, B., Murillo, L., Blondal, T., Kolbeinsson, H., Stefansson, J. G., Hansdottir, I., Runarsdottir, V., Pola, R., Lindblad, B., van Rij, A. M., Dieplinger, B., Haltmayer, M., Mayordomo, J. I., Kiemeney, L. A., Matthiasson, S. E., Oskarsson, H., Tyrfingsson, T., Gudbjartsson, D. F., Gulcher, J. R., Jonsson, S., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
- Affiliations
- deCODE Genetics (Iceland) (IS)
- University of Otago (NZ)
- Convent Hospital of the Brothers of Saint John of God (AT)
- Skåne University Hospital (SE)
- Università Cattolica del Sacro Cuore (IT)
- Radboud University Medical Center (NL)
- Hospital Universitario Reina Sofía (ES)
- National University Hospital of Iceland (IS)
- Instituto de Nanociencia y Materiales de Aragón (ES)
- Corresponding author
- Thorgeirsson, Thorgeir E.
- ORCID
- Venue
- Nature
- Published
- 2008-04
- Volume
- 452
- Issue
- 7187
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4539558
- OpenAlex
- W2118082971
- Cited by
- 1,523
- References
- 45
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 29 · 2023: 41 · 2022: 33 · 2021: 36 · 2020: 94 · 2019: 48 · 2018: 56 · 2017: 79 · 2016: 80 · 2015: 107 · 2014: 91 · 2013: 100 · 2012: 145
- FWCI
- 120.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- European Commission
- National Institute on Drug Abuse (R01DA017932)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- nicotinic acetylcholine receptors, nicotine dependence, smoking quantity, lung cancer susceptibility, peripheral arterial disease, gene-environment interaction, genetic susceptibility, smoking-related diseases
- MeSH terms
- Chromosomes, Human, Pair 15, Europe, Female, Multigene Family, Genotype, Humans, Lung Neoplasms, Male, New Zealand, Receptors, Nicotinic, Smoking, Tobacco Use Disorder, Odds Ratio, Peripheral Vascular Diseases, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.